Michael Zeisser
Member of the Media Advisory Group @ American Association for the Advancement of Science
San Francisco, United States
Michael Zeisser is a Series A investor at American Association for the Advancement of Science in San Francisco focused on Software and Health Care. Michael Zeisser is Chairman US Investments for Alibaba Group, one of the largest internet companies in the world, where he is responsible for backing entrepreneurial teams working on innovative platforms, products and ideas with a focus on Internet commerce and emerging technologies.Prior to Alibaba Group, Michael spent almost a decade leadingactivities in digital media and Internet commerce at Liberty Media. Michael created and oversaw Liberty Media's Digital Commerce Group, a roll-up of specialty online retail companies which grew to generate revenues of $1.5 billion and comprised leading brands such as Proflowers.com, RedEnvelope.com, Gifts.com, Backcountry.com, Bodybuilding.com, Motosport.com, and Evite.com.Prior to joining Liberty Media in 2003, Zeisser was a partner at McKinsey & Company in New York, where he co-founded and led McKinsey's Internet Practice, in addition to being a member of the firm's Media & Entertainment and Private Equity practices. Zeisser was one of McKinsey's leading experts on internet businesses and digital transition strategies in the consumer media, advertising, travel, and packaged goods industries.Zeisser has previously served on the boards of Trip Advisor (Nasdaq:TRIP), IAC/InterActiveCorp. (Nasdaq:IACI), QVC Inc, GSN - The Network for Games, and Sling Media. He is currently a member of the Advisory Board of the Silicon Flatirons Center for Law, Technology and Entrepreneurship at the University of Colorado, and the Media Advisory Group of the American Association for the Advancement of Science.Zeisser earned a business degree with honors from the University of Strasbourg, France and an MBA with distinction from the J.L. Kellogg Graduate School of Management at Northwestern University, where he was a Procter & Gamble International Academic Scholar.
- Total investments:
- 12
- Last investment:
- Lead investor:
- 8%
Last updated:
For AI agents: llms.txt
Industries Michael Zeisser invests in
Stages Michael Zeisser invests in
Countries Michael Zeisser invests in
Round sizes
Round size
- Seed
- $4.5M–$5.5M
- Series A
- $10M–$25M
- Series C
- $30M–$153M
Investment Focus
Industry
- Software 3 (25%)
- Health Care 3 (25%)
- SaaS 2 (17%)
- Travel 2 (17%)
- E-Commerce 2 (17%)
Stage
- Series A 3 (25%)
- Series C 3 (25%)
- Seed 2 (17%)
- Series B 1 (8%)
- Series D 1 (8%)
Country
- United States 4 (33%)
- United Kingdom 2 (17%)
- Israel 1 (8%)
- Germany 1 (8%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
InStride Health
|
InStride Health provides evidence-based OCD and anxiety treatment to keep kids and teenagers engaged along the way. | $30M / Series C / Jun 15, 2026 | |
HeyJobs
|
HeyJobs is a Talent Platform that helps employers find the right talents at a friction of the traditional cost per hire. It helps talents find jobs that enable them to live a fulfilling life. Through a combination of machine learning, automation and software, we have created >50'000 hires already. | $47M / Series B / Mar 24, 2022 | |
Fresha
|
Fresha is a marketplace that allows consumers to discover, book and pay for beauty and wellness appointments with local businesses, while salons, spas and barbershops can leverage Fresha to manage their operations with its intuitive, subscription-free business software. Fresha empowers business owners by managing appointment bookings,point-of-sale, customer records, human resources, inventory, and financial reporting. The consumer marketplace unlocks revenue potential for partner businesses by leveraging the power of online bookings and automated marketing through mobile apps and integrations to Instagram, Facebook and Google.Fresha was founded in 2015 and is headquartered in London, United Kingdom. | $52.5M / Series C / Dec 14, 2021 | |
Easol
|
The all-in-one platform to manage your experience business, on your terms. | $25M / Series A / Dec 08, 2021 | |
NeuroKaire
|
NeuoKaire (formerly Genetika+) is developing a personalized medical testing tool to better treat depression by helping physicians find the best drug therapy for their patients. The Genetika+ test uses innovative technology to predict the best drug treatment for each patient, enabling faster treatment, fewer side effects, and lower dosing. | $10M / Series A / Sep 30, 2021 | |
|
Fresha
|
Fresha is a marketplace that allows consumers to discover, book and pay for beauty and wellness appointments with local businesses, while salons, spas and barbershops can leverage Fresha to manage their operations with its intuitive, subscription-free business software. Fresha empowers business owners by managing appointment bookings,point-of-sale, customer records, human resources, inventory, and financial reporting. The consumer marketplace unlocks revenue potential for partner businesses by leveraging the power of online bookings and automated marketing through mobile apps and integrations to Instagram, Facebook and Google.Fresha was founded in 2015 and is headquartered in London, United Kingdom. | $152.5M / Series C / Jun 11, 2021 | |
|
Easol
|
The all-in-one platform to manage your experience business, on your terms. | $4.5M / Seed / Mar 04, 2021 | |
|
Easol
|
The all-in-one platform to manage your experience business, on your terms. | $4.5M / Venture - Series Unknown / Mar 04, 2021 | |
Curated
|
Curated is a provider of collaborative online shopping service intended to assist shoppers with high-consideration purchases. The company's platform matches customers with experts for high-consideration purchases: items that have some degree of complexity, enabling shoppers to get access to unbiased product recommendations and good deals,handpicked by real experts. | $22M / Series A / Oct 30, 2019 | |
|
Curated
|
Curated is a provider of collaborative online shopping service intended to assist shoppers with high-consideration purchases. The company's platform matches customers with experts for high-consideration purchases: items that have some degree of complexity, enabling shoppers to get access to unbiased product recommendations and good deals,handpicked by real experts. | $5.5M / Seed / Oct 30, 2019 | |
| See all 12 investments → | |||
Co-Investors
About American Association for the Advancement of Science
American Association For The Advancement Of Science (AAAS) is an international non-profit organization focused on developing and supporting scientific education, science outreach, promoting cooperation among scientists, defending scientific freedom, and encouraging scientific responsibility. AAAS publishes four journals: Science, Science Signaling,Science Translational Medicine, and Science Advances.AAAS’s education enhancement programs include Education and Human Resources: a program that helps science students and professionals to build bridges to careers in the fields of science, technology, engineering, and mathematics; Project 2061: a long-term research and development initiative focused on making all Americans literate in science, mathematics, and technology before Halley’s comet returns in 2061; STEM Volunteer Program: a program that places retired science professionals in K-12 classrooms to foster STEM literacy in students and motivate them to pursue STEM careers; and Science NetLinks: a website that offers standards-based lesson plans, online tools, special resource collections, and after-school activities for K-12 teachers, students, and families. Science Diplomacy, Science & Diplomacy, and Science, Technology & Security Policy are its global outreach programs.AAAS conducts press and public engagement programs to make science and technology information accessible to everyone. It provides objective analysis to decision makers and helps experts contribute to policy-making.American Association For The Advancement Of Science was founded on September 20, 1848, and is based in District of Columbia, United States.
American Association for the Advancement of Science Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Michael Zeisser
Member of the Media Advisory Group
|
|||
Dan Voytas
Fellow
|
|||
Eric Davidson
Team Member
|
|||
Gadi Ben-Yehuda
Social Media Director
|
|||
Gary Glick
Fellow
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Michael Zeisser invest in?
Michael Zeisser invests primarily in Software, Health Care and SaaS startups, most often at Series A and Series C stage. Most of the 12 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Michael Zeisser's check size?
Michael Zeisser typically joins rounds of $4.5M–$5.5M at Seed, $10M–$25M at Series A and $30M–$153M at Series C. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Michael Zeisser participates in.
When did Michael Zeisser last invest?
The most recent investment recorded for Michael Zeisser closed in Jun 2026. Shizune tracks 12 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
